We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

STS Biopolymers Grants License to Jomed for Stent Coating

By HospiMedica staff writers
Posted on 08 Apr 2003
A license agreement has been announced that grants rights to a drug delivery coating for stents developed by STS Biopolymers (Henrietta, NY, USA) to Jomed GmbH (Freiburg, Germany). More...


The drug delivery technology of STS Biopolymers enables single or multiple drug combinations to be released over controllable time periods, ranging from days to weeks or months. Used in combination with a primer called Bond-Coat, the coating is permanently adhered to a stent while providing the flexibility needed for placement and expansion. In a one-month coronary study in pigs, the polymer matrix was found to be biocompatible, with no increased inflammation reaction. Jomed is using the coating on stents to prevent restenosis.

"We are very pleased that Jomed has chosen to work with Biopolymers to utilize the Medi-Coat drug release coating for stents. Jomed has selected a proprietary drug technology for incorporation into the Medi-Coat coating,” said Richard Whitbourne, chairman of STS Biopolymers. "We expect the Jomed stent product to move very quickly to market, but to be followed by other important products using the Medi-coat coating platform.





Related Links:
STS Biopolymers
Jomed

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Hybrid Arch Device
Neo EDE
New
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.